Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Pacific Bridge NY (PBNY) is a venture fund established to unlock cross-border biotech value, particularly between Asia and the West. Founded with the mission to advance high-quality global intellectual property, PBNY employs cost-effective clinical development strategies to enhance the drug development landscape. The firm leverages its connections with Asian preclinical and clinical companies to facilitate this process.
Currently, PBNY operates globally, with a strong emphasis on North America and Asia. The firm focuses on various investment stages, ranging from pre-seed to growth equity, and has built a team of experienced professionals in the biotech sector. Their approach is designed to support innovative biotech companies that can navigate the complexities of drug development and commercialization.
Pacific Bridge NY invests primarily in the biotech and healthcare sectors, targeting companies and programs that exhibit strong biological rationale and clear paths to approval in Western markets. The firm emphasizes cross-border opportunity sourcing, clinical expertise, and flexible company-building structures. PBNY seeks to support opportunities where global intellectual property can be licensed or partnered, and where international preclinical or clinical expertise can be utilized.
The investment stages range from pre-seed to growth equity, allowing PBNY to engage with startups at various points in their development. The firm’s geographic focus spans globally, with particular attention to opportunities in Asia and North America. This strategic positioning enables PBNY to capitalize on unique market dynamics and foster partnerships that enhance drug development.
Marc S. Appel - Managing Partner. Marc has extensive experience in the biotech sector, having led numerous successful investments and strategic initiatives.
Joe Walker - Partner. Joe brings a wealth of knowledge in clinical development and has been instrumental in sourcing cross-border opportunities.
Min (Winnie) Wang - Partner. Winnie specializes in global intellectual property and has a strong background in biotech commercialization.
Jarrat Jordan - Venture Advisor. Jarrat provides strategic guidance and insights into the biotech landscape, enhancing PBNY's investment strategies.
Founders should pitch Pacific Bridge NY via email at info@pacificbridgeny.com. A concise pitch deck that includes the business model, market opportunity, and clinical development strategy is essential. Response times may vary, so patience is advised.
What are Pacific Bridge NY's investment criteria?
PBNY focuses on biotech companies that demonstrate strong biological rationale and clear paths to approval in Western markets. They prioritize cross-border opportunities and clinical expertise.
How can I pitch to Pacific Bridge NY?
Founders can reach out via email at info@pacificbridgeny.com. A well-structured pitch deck that outlines the business model, market opportunity, and clinical development strategy is recommended.
What makes Pacific Bridge NY different from other investors?
PBNY specializes in cross-border biotech investments, leveraging connections with Asian clinical companies to enhance drug development strategies. Their focus on global intellectual property sets them apart.
What is the geographic scope of Pacific Bridge NY's investments?
The firm invests globally, with a particular emphasis on North America and Asia, allowing them to tap into diverse biotech ecosystems.
What stages of investment does Pacific Bridge NY engage in?
PBNY invests across multiple stages, including pre-seed, seed, Series A, Series B, Series C, and growth equity, providing flexibility in their investment approach.
What kind of post-investment involvement can founders expect?
PBNY provides operational support and access to their network of clinical experts, helping portfolio companies navigate the complexities of drug development.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.